IM Cannabis (IMCC) Notes Payables (2021 - 2026)
IM Cannabis (IMCC) posted quarterly Notes Payables of $10.3 million for Q4 2025, down 5.2% year-over-year from $10.8 million in Q4 2024, and up 6.88% quarter-over-quarter from $9.6 million in Q2 2025.
IM Cannabis (IMCC) Notes Payables (2021 - 2026) Analysis & Trends
IM Cannabis' Notes Payables history runs 5 years deep, the most recent figure standing at $10.3 million for Q4 2025.
- In Q4 2025, Notes Payables fell 5.2% year-over-year to $10.3 million; the TTM figure through Dec 2025 stood at $10.3 million (down 5.2% YoY), while the FY2025 annual figure was $10.3 million, down 7.09% from the prior year.
- Notes Payables for Q4 2025 stood at $10.3 million, up from $9.6 million in the prior quarter.
- The five-year high for Notes Payables was $14.1 million in Q2 2022, with the low at $6.8 million in Q4 2022.
- The 5-year median for Notes Payables is $9.3 million (2024), against an average of $9.5 million.
- Peak annual rise in Notes Payables reached 30.69% in 2023, while the deepest fall reached 39.49% in 2023.
- IM Cannabis' Notes Payables stood at $6.9 million in 2021, then declined by 1.13% to $6.8 million in 2022, then jumped by 30.69% to $8.9 million in 2023, then gained by 21.79% to $10.8 million in 2024, then dropped by 5.2% to $10.3 million in 2025.
- Business Quant data shows IMCC's Notes Payables at $10.3 million in Q4 2025, $9.6 million in Q2 2025, and $10.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.24 Mn |
| Dec 31, 2025 | 10.28 Mn |
| Jun 30, 2025 | 9.62 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Jun 30, 2024 | 9.32 Mn |
| Dec 31, 2023 | 8.90 Mn |
| Jun 30, 2023 | 8.54 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Jun 30, 2022 | 14.12 Mn |
| Dec 31, 2021 | 6.89 Mn |